retatrutide approval status 2025 retatrutide fda approval HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ is not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and Retatrutide: What It Is &
Description
These medications are not generally recommended while pregnant or breastfeeding
Do not freeze reconstituted peptide, as the freeze-thaw cycle damages protein structure
As Retatrutide is still in trials, full risk profiles are being studied
It is to keep skin feeling cared for while change is happening
